Fortrea Holdings Inc.

XNASHealth care

Last traded price · USD

$19.00

−8.79%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $20.83
Volume: 11
Day's high: —
Day's low: —

In brief

Fortrea Holdings Inc. is a health care company listed on Nasdaq, valued at about $1.83B.
Its shares closed at $20.83 on 4 Nov 2026, up 114.7% over the past year.
From India you can buy FTRE in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Fortrea Holdings Inc. (FTRE) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole FTRE share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade FTRE options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: +0.2% (SPY −1.6%, XLV +13.5%). 3 months: +9.3% (SPY −0.4%, XLV +15.5%). 1 year: +114.7% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: FTRE, SPY and XLV · as of 4 Nov 2026
Volume 2.7× its 30-session average on 29 Oct 2026
29 Oct 2026 volume of 5.0M shares was 2.7× the average of the 30 sessions before it (1.8M), as the price fell 10.6%. SPY traded 1.0× its own average that session.
Daily volume against a 30-session baseline · as of 29 Oct 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $20.83 was 2.0% above its 50-day average ($20.41) and 32.1% above its 200-day average ($15.76). It has closed above the 200-day for 131 sessions, since 30 Apr 2026. The 50-day average crossed above the 200-day on 5 Jun 2026, 105 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
70% of the way up its 52-week range
Closed at $20.83 on 4 Nov 2026: 20.4% below the 52-week high of $26.16 (28 Oct 2026) and 143.6% above the low of $8.55 (6 Apr 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 8.0% of shares outstanding
7.7M shares were sold short at the 15 Oct 2026 settlement, 8.0% of the 96.5M shares outstanding; covering them would take 4.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+0.2%

6 months+33.2%

1 year+114.7%

5 years—

Newswire

About

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Website

Notable moves

July 22, 2025
+24.46%
March 3, 2025
−25.05%
November 8, 2024
+30.19%

Fortrea Holdings Inc.

XNASHealth care

Last traded price · USD

$19.00

−8.79%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $20.83
Volume: 11
Day's high: —
Day's low: —

In brief

Fortrea Holdings Inc. is a health care company listed on Nasdaq, valued at about $1.83B.
Its shares closed at $20.83 on 4 Nov 2026, up 114.7% over the past year.
From India you can buy FTRE in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Fortrea Holdings Inc. (FTRE) shares from India?

Do I need the price of a whole FTRE share to invest?

How much can I invest in US stocks in a year?

Can I trade FTRE options or futures?

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: +0.2% (SPY −1.6%, XLV +13.5%). 3 months: +9.3% (SPY −0.4%, XLV +15.5%). 1 year: +114.7% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: FTRE, SPY and XLV · as of 4 Nov 2026
Volume 2.7× its 30-session average on 29 Oct 2026
29 Oct 2026 volume of 5.0M shares was 2.7× the average of the 30 sessions before it (1.8M), as the price fell 10.6%. SPY traded 1.0× its own average that session.
Daily volume against a 30-session baseline · as of 29 Oct 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $20.83 was 2.0% above its 50-day average ($20.41) and 32.1% above its 200-day average ($15.76). It has closed above the 200-day for 131 sessions, since 30 Apr 2026. The 50-day average crossed above the 200-day on 5 Jun 2026, 105 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
70% of the way up its 52-week range
Closed at $20.83 on 4 Nov 2026: 20.4% below the 52-week high of $26.16 (28 Oct 2026) and 143.6% above the low of $8.55 (6 Apr 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 8.0% of shares outstanding
7.7M shares were sold short at the 15 Oct 2026 settlement, 8.0% of the 96.5M shares outstanding; covering them would take 4.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+0.2%

6 months+33.2%

1 year+114.7%

5 years—

Newswire

About

Website

Notable moves

July 22, 2025
+24.46%
March 3, 2025
−25.05%
November 8, 2024
+30.19%

Fortrea Holdings Inc.

Fortrea Holdings Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

Volume 2.7× its 30-session average on 29 Oct 2026

Above its 50- and 200-day averages

70% of the way up its 52-week range

Short interest at 8.0% of shares outstanding

Fortrea Holdings Inc.

Fortrea Holdings Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

Volume 2.7× its 30-session average on 29 Oct 2026

Above its 50- and 200-day averages

70% of the way up its 52-week range

Short interest at 8.0% of shares outstanding